- Home
- QURE vs NOMD Comparison
QURE vs NOMD Comparison
Compare QURE & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | NOMD |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | QURE | NOMD |
|---|---|---|
| Price | $23.37 | $12.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $56.25 | $18.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142.93 | $1.36 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $11.04 |
| 52 Week High | $71.50 | $20.81 |
Technical Indicators
Market Signals| Indicator | QURE | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 51.61 |
| Support Level | $20.17 | $12.48 |
| Resistance Level | $26.97 | $12.94 |
| Average True Range (ATR) | 2.25 | 0.25 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 38.75 | 35.17 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.